openPR Logo
Press release

Contraceptives Market to Witness Exponential Growth US$ 62 Billion by 2033 | Fact.MR

05-09-2024 05:25 PM CET | Health & Medicine

Press release from: Fact.MR

Contraceptives Market to Witness Exponential Growth US$ 62

The global contraceptives market (避妊薬市場) is projected to grow significantly, with its value expected to rise from US$ 33 billion to US$ 62 billion by 2033. This growth is primarily attributed to robust government campaigns and programs aimed at improving women's and children's health. Government initiatives and programs promoting women's and children's health are driving the adoption of contraceptive methods. Copper intrauterine devices (IUDs) are particularly popular among women who prefer non-hormonal options to avoid potential side effects.

Get Free Sample Copy of This Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=4719

Contraception, also known as fertility control or birth control, involves the use of medication or devices to prevent pregnancy. Various contraceptive methods are available, and the most suitable method depends on an individual's health and circumstances. These methods work by disrupting the normal fertilization process between sperm and egg, thereby preventing conception.

Key Driving Forces Accelerating the Market Growth:

Growing Awareness: Increased awareness about family planning and contraception methods has spurred demand for contraceptives. Educational campaigns have played a crucial role in promoting contraceptive use and empowering individuals to make informed decisions.

Technological Advancements: Advancements in contraceptive technologies, such as the development of long-acting reversible contraceptives (LARCs) like intrauterine devices (IUDs) and implants, offer improved convenience, effectiveness, and reduced side effects, driving adoption rates.

Regional Dynamics: Regions like North America, with a 50% share of the global market, witness growth due to rising unintended pregnancies, demand for reversible contraceptives, and government initiatives providing funding for family planning services.

Government Programs: Government programs and policies promoting access to contraceptives have fueled market growth. Subsidized programs and increased funding for family planning services have made contraceptives more accessible and affordable.

Workforce Participation: The increasing number of women in the workforce has led to higher demand for contraceptives. Women pursuing careers opt for contraception to control reproductive choices and plan for desired family sizes.

Changing Social Attitudes: Shifting social attitudes towards sexual health and reproductive rights have contributed to market growth. Discussions on gender equality, individual autonomy, and women's empowerment have driven more people to seek contraceptive options to exercise control over their reproductive health.

Key Companies Profiled in This Report

Evofem Biosciences
CooperSurgical, Inc.
Actavis, Inc.
Medisafe Distribution Inc.
Mayer Laboratories, Inc.
Mylan
Allergan Plc.
Veru Inc.
CooperSurgical, Inc.
Pfizer Inc.

Competitive Landscape:

Competition in the contraceptive market (피임약 시장) drives innovation and product development, as companies strive to offer new and improved options with greater effectiveness, convenience, safety, and fewer side effects. Key players focus on research and development (R&D) to introduce modern devices and enhance product standards. Acquisitions and collaborations are common strategies to strengthen market presence.

For example, in 2021, Cooper Surgical Inc. acquired Generate Life Sciences, enhancing its reproductive section. Clue introduced a digital birth control method, providing users with an ovulation tracker. Pfizer Inc. launched Sayana Press, the first injectable contraceptive for women in the U.K., and is studying levonorgestrel and Ethinyl estradiol as potential oral contraceptives. Merck & Co, Inc. offers various contraceptive options, including oral pills, vaginal rings, intrauterine devices, and sub-dermal implants. Cipla manufactures Crisanta, an oral contraceptive containing Drospirenone, which prevents fertilization and induces hormonal changes to prevent pregnancy.

Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=RC&rep_id=4719

Key Segments of Contraceptives (Markt für Verhütungsmittel) Industry Research

By Product :

Contraceptive Drugs

Contraceptive Devices

By Distribution Channel :

Hospital Pharmacies

Independent Pharmacies

Online Platforms

Clinics

Others

By Region :

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Contact:

US Sales Office

11140 Rockville Pike

Suite 400 Rockville, MD 20852

United States Tel: +1 (628) 251-1583, +353-1-4434-232 (D)

Sales Team: sales@factmr.com

About Fact.MR :

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Contraceptives Market to Witness Exponential Growth US$ 62 Billion by 2033 | Fact.MR here

News-ID: 3491377 • Views:

More Releases from Fact.MR

3D Body Scanners Market Set for Remarkable Growth, Expected to Surpass US$ 264 Million by 2027 at 14.9% CAGR
3D Body Scanners Market Set for Remarkable Growth, Expected to Surpass US$ 264 M …
By the end of 2027, the global 3D body scanners market is expected to have grown from its current valuation of US$ 131.5 million to US$ 264 million. Over the next five years, sales of 3D body scanners are expected to rise at a remarkable CAGR of 14.9% worldwide. Compared to other industries, the gaming and retail sectors are expected to have a higher demand for 3D body scanners in the
Confectioneries Market Projected to Reach US$ 474 Billion by 2033, Growing at a CAGR of 4.6%
05-20-2024 | Food & Beverage
Fact.MR
Confectioneries Market Projected to Reach US$ 474 Billion by 2033, Growing at a …
In 2023, the worldwide confectionery market is expected to be valued at US$ 301 billion. Confectionery sales are predicted to grow at a 4.6% CAGR over the following 10 years, to reach a value of US$ 474 billion by the end of 2033. Around the world, sweet treats of any form are regarded as popular foods. Confectioneries are sugary treats that are high in carbs. They take the shape of biscuits,
Aqua Gym Equipment Market Is Projected To Reach US$ 1.01 Billion By 2033: Fact.MR Report
Aqua Gym Equipment Market Is Projected To Reach US$ 1.01 Billion By 2033: Fact.M …
The global aqua gym equipment market, valued at US$ 620.13 million in 2023, is projected to reach US$ 1.01 billion by 2033. This growth reflects a compound annual growth rate (CAGR) of 5% over the forecast period from 2023 to 2033. The Aqua Gym Equipment Industry sales study offers a comprehensive analysis on diverse features including production capacities, Aqua Gym Equipment demand, product developments, sales revenue generation and Aqua Gym Equipment
Rimless Toilets Market Is Forecasted To Reach US$ 20.41 Billion By 2033: Fact.MR Report
Rimless Toilets Market Is Forecasted To Reach US$ 20.41 Billion By 2033: Fact.MR …
According to a recent study published by Fact.MR, the global rimless toilets market is valued at US$ 16.74 billion in 2023. The demand for rimless toilets worldwide is expected to grow at a compound annual growth rate (CAGR) of 2%, reaching a market value of US$ 20.41 billion by the end of 2033. The Rimless Toilets Industry sales study offers a comprehensive analysis on diverse features including production capacities, Rimless Toilets

All 5 Releases


More Releases for Contraceptive

Contraceptive Rings Market Segmentation By product type Etonogestrel/Ethinyl est …
Contraceptive rings are smooth, flexible round shaped plastic rings which are meant to insert into vagina to on first day woman’s menstrual cycle to prevent possible pregnancy. When contraceptive rings are placed into the vagina it releases two hormones named estrogen and progestogen which are similar to natural hormones released by the body and which are also used in the contraceptive pills. Contraceptive rings release continuous dose of these hormones
Contraceptive Pills
Oral contraceptive pills is a kind of female hormonal anti-conception medication technique that is used for avoiding pregnancy. Contraceptive drugs are used to prevent the unwanted pregnancy by blocking the normal process of ovulations or by altering the process which support the fertilization of egg. The prevalence of women with unmet contraception needs was accounted at 214 million in 2018 by WHO. Further, as indicated by, United Nations,
Contraceptive Rings Market Segmentation By product type Etonogestrel/Ethinyl est …
Contraceptive rings are smooth, flexible round shaped plastic rings which are meant to insert into vagina to on first day woman’s menstrual cycle to prevent possible pregnancy. When contraceptive rings are placed into the vagina it releases two hormones named estrogen and progestogen which are similar to natural hormones released by the body and which are also used in the contraceptive pills. Contraceptive rings release continuous dose of these hormones
U.S. Contraceptives Drugs And Devices Market, By Product Type (Contraceptive Dru …
Contraceptive Drugs and Devices – Choice to Conceive, Not Concede As per stats released by Guttmacher Institute, there were around 61 million women in the U.S. in the childbearing age group (15-44 years) in 2014. Around 10% of these women do not use any contraceptive method. The UN estimates (2015) that unmet need for contraceptives in the North America region is 7%. Thus, there still is an untapped market in the
Global Contraceptives Drugs And Devices Market, By Product Type (Contraceptive D …
Contraceptives are birth spacing products that aid in avoiding unwanted/ unplanned pregnancy. There are five widely used contraceptive methods namely barrier method, hormonal method, emergency contraception, intrauterine method, and sterilization. Women can opt for wide range of contraceptive options such as vaginal rings, diaphragms, female condoms, oral pills, and intra-uterine devices (IUD). Selecting the most appropriate method is critical to avoid undesired side effects. The use of contraceptives can avoid
Oral Contraceptive Pills Market: Snapshot
Teva Pharmaceutical is one of the leading companies in the combination oral contraceptive pills segment and is followed by Allergan (Actavis) plc. Local manufacturers such as Alkem, Taj Pharma, and Zydus Alidec on the other hand, held a majority of the market for ormeloxifene and mifepristone. Transparency Market Research has observed that almost all manufacturers offer combination oral contraceptive pills owing to the fact that they are more efficient, cost